US FDA Commissioner Race Shrinks And Widens: Biden Team Trying To Woo Reluctant Dems On Woodcock While Exploring New Options
Executive Summary
White House is trying to overcome some Senate Democrats’ opposition to Janet Woodcock as FDA Commissioner, while also looking for other candidates for the job. Josh Sharfstein, long thought to be Woodcock’s main competition, is not a strong contender.
You may also be interested in...
Trove Of Opioid Documents May Help Shape Public Health Policy
As sponsors and US FDA continue to face fallout, newly launched digital archive of industry documents from opioid litigation and settlements will be free public resource for those investigating activities that led to the opioid epidemic. It is modeled on the archive of tobacco industry documents, which has been the basis of about 1,000 scientific publications.
White House Reiterates Confidence In FDA Expertise, Independence With J&J Vaccine Pause
Not only did White House and other officials support the recommendation, but also made clear they had no advance notice of it.
Advanced Manufacturing May Require US FDA To Think Differently About Guidance
National Academies report argues that technologies cannot only be evaluated in the context of specific products, and FDA guidance should become both ‘more fluid and targeted.’